RecruitingThyroid Gland Nodule
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
Eligible age
19+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This trial studies how well the diagnostic deoxyribonucleic acid (DNA) methylation signature works in detecting thyroid cancer in patients with thyroid nodules. Using diagnostic testing, such as the diagnostic DNA methylation signature, may be a less invasive way to check for thyroid cancer.
Sponsor: City of Hope Medical Center
You may qualify if…
- ✓ All patients undergoing FNA for thyroid nodule diagnosis.
- ✓ Any race and ethnicity are eligible for the study.
- ✓ Patient should have thyroid nodule(s) with indeterminate diagnosis after FNA (Bethesda category of indeterminate FNA \[III-V\]).
Where it's recruiting
California
Duarte
Source: ClinicalTrials.gov · NCT03676647 · last updated 2026-06-02